Kavitha Nowroji, Vijayarathna Soundararajan, Jothy Subramanion Lachumy, Oon Chern Ein, Chen Yeng, Kanwar Jagat Rakesh, Sasidharan Sreenivasan
Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang, Malaysia E-mail :
Asian Pac J Cancer Prev. 2014;15(18):7489-97. doi: 10.7314/apjcp.2014.15.18.7489.
MicroRNAs (miRNAs) are short non-coding RNAs of 20-24 nucleotides that play important roles in carcinogenesis. Accordingly, miRNAs control numerous cancer-relevant biological events such as cell proliferation, cell cycle control, metabolism and apoptosis. In this review, we summarize the current knowledge and concepts concerning the biogenesis of miRNAs, miRNA roles in cancer and their potential as biomarkers for cancer diagnosis and prognosis including the regulation of key cancer-related pathways, such as cell cycle control and miRNA dysregulation. Moreover, microRNA molecules are already receiving the attention of world researchers as therapeutic targets and agents. Therefore, in-depth knowledge of microRNAs has the potential not only to identify their roles in cancer, but also to exploit them as potential biomarkers for cancer diagnosis and identify therapeutic targets for new drug discovery.
微小RNA(miRNA)是一类长度为20 - 24个核苷酸的短链非编码RNA,在癌症发生过程中发挥着重要作用。因此,miRNA控制着众多与癌症相关的生物学事件,如细胞增殖、细胞周期调控、代谢和细胞凋亡。在本综述中,我们总结了目前关于miRNA生物发生、miRNA在癌症中的作用及其作为癌症诊断和预后生物标志物的潜力的知识和概念,包括对关键癌症相关途径的调控,如细胞周期控制和miRNA失调。此外,微小RNA分子作为治疗靶点和药物已经受到全球研究人员的关注。因此,深入了解微小RNA不仅有可能确定它们在癌症中的作用,还能将它们开发为癌症诊断的潜在生物标志物,并确定新药研发的治疗靶点。